GLP-1 Weight Loss in Springfield, MA: 39.6% Obesity, a Price-Opaque Local Market, and Astra's Fixed $68/mo Rate
Springfield's obesity and income gap inside a high-income state, an unconfirmed MassHealth picture, HRSA shortage designations, and the one clinic that publishes prices.
39.6% of Springfield adults have obesity (CDC PLACES 2025 release, crude prevalence, BRFSS 2023) 1, against Hampden County 2 and a Massachusetts statewide rate of 27.4% 3. The income gradient tells the same story: city median household income is $52,656 versus Hampden County's $71,306 and Massachusetts's $103,960, roughly 26% below its own county and 49% below the state 46.
Springfield is the poorer, heavier outlier inside a thin, high-income state: 154,749 residents in a 462,815-person metro, with 3.8% uninsured 45.
Springfield carries multiple active HRSA shortage designations (accessed Aug 28, 2026, HRSA Data Downloads BCD_HPSA_FCT_DET_PC/MH/DH.csv). A Low-Income Population Primary Care HPSA covers "Springfield/Chicopee/Holyoke" (score 9, designated population 99,492, 22.7% below poverty, ~12,283 estimated underserved). Two facility-level HPSAs sit inside city limits at Federally Qualified Health Centers: Caring Health Center (1049 Main St, 01103) — Primary Care score 16, Mental Health score 17, Dental Health score 18 — and a city-run health center at 311 State St, 01105, listed by HRSA only as "HEALTH & HUMAN SERVICES" (HRSA's own download truncates the full legal name; unconfirmed beyond that) — Primary Care score 15, Mental Health score 15, Dental Health score 19. A county-wide Low-Income Mental Health HPSA (Hampden County, score 19, population 139,581) also applies. Net read: primary care, behavioral health, and dental access for Springfield's low-income population are all formally designated shortage areas.7
Specialist access
Springfield hosts Baystate Medical Center, Western Massachusetts's academic referral hub, which runs an in-house Endocrinology & Diabetes department — hospital-based specialist capacity for obesity-adjacent care is comparatively strong for a tier-2 city. The real gap sits one level down: HRSA's active HPSA designations show Springfield's low-income population is short on primary care — the actual first-line access point for most GLP-1 prescribing and ongoing management — plus behavioral health and dental. Specialists exist at the hospital; the primary-care front door to get referred or prescribed in the first place is formally understaffed for the population that needs it most.8
Medicaid coverage note
UNVERIFIED — DO NOT PUBLISH SPECIFIC FIGURES UNTIL CONFIRMED. A single research pass surfaced a claim, attributed to WBUR ("Mass. cutting GLP-1 coverage," June 23, 2026), that MassHealth (Massachusetts Medicaid) ended coverage of Wegovy/Zepbound for weight-loss indications effective July 1, 2026 — citing ~$15M/year in projected savings and affecting 22,000+ enrollees statewide, who reportedly face ~$450/month out-of-pocket, a switch to another drug, or going without. This could NOT be independently corroborated this session: direct mass.gov access returned HTTP 403 (bot protection), and no second source (Boston Globe, MassLive, State House News Service, KFF's state Medicaid GLP-1 tracker) turned up via the search channels available. Treat every figure above as an open TODO, not a fact, until a primary MassHealth bulletin or a directly-verified dated article confirms it. No Springfield- or Hampden-County-specific enrollee count exists even if the statewide claim checks out.15
MassHealth coverage is unconfirmed this review cycle
Massachusetts Medicaid is MassHealth. As of this page's last review, we could not independently confirm current MassHealth coverage rules for GLP-1 weight-loss prescriptions. Check directly with MassHealth or your plan. A claimed change surfaced in research but failed independent verification, so nothing about it is stated here as fact 15.
What is confirmed and dated is the local shortage picture, accessed Aug 28, 2026. A Low-Income Population Primary Care HPSA covers Springfield/Chicopee/Holyoke (score 9, designated population 99,492, 22.7% below poverty, roughly 12,283 estimated underserved). Two facility-level HPSAs sit inside city limits at federally qualified health centers: Caring Health Center at 1049 Main St (primary care score 16, mental health 17, dental 18) and a city-run health center at 311 State St, listed by HRSA only as "HEALTH & HUMAN SERVICES" because HRSA's download truncates the legal name, plus a county mental-health designation 7.
What GLP-1 care costs in Springfield today
Renew Weight Loss & Med Spa, at 235 Chestnut St, is the only Springfield clinic found publishing real GLP-1 self-pay pricing, spread across several pages of its own site: compounded semaglutide $329/mo in person or $299/mo on its Express Lane text-check-in tier, and compounded tirzepatide $429/mo in person or $399/mo Express Lane, with a separate brand-name tier on its medical-weight-loss page 91011. The same clinic advertises a roughly $125/mo "Medicare Bridge" offer, which is the clinic's own unverified claim rather than an established program 12.
The other two are call-only. Botastic Wellness Center at 673 B White St advertises a medically supervised weight-loss program with no semaglutide, tirzepatide, or GLP-1 dollar pricing anywhere on-site 13, and New England Center for Functional Medicine at 2 Medical Center Dr, Suite 202, lists medical weight loss among its services and discloses no GLP-1 pricing, requiring a call or new-patient registration for a quote 14. That opacity is part of the finding, not an omission.
Astra's price is national and flat: $68/month for semaglutide and $118/month for tirzepatide on 12-month plans, the same in every city.
Hospital specialists, an understaffed front door
Springfield hosts Baystate Medical Center, Western Massachusetts's academic referral hub, which runs an in-house Endocrinology & Diabetes department 8. Hospital-based specialist capacity for obesity-adjacent care is comparatively strong for a tier-2 city.
The gap sits one level down. HRSA's active designations show Springfield's low-income population is short on primary care, the first-line access point for most GLP-1 prescribing and ongoing management, plus behavioral health and dental 7. Specialists exist at the hospital; the primary-care front door needed to get referred or prescribed is formally understaffed for the population that needs it most.
Telehealth removes that primary-care-referral bottleneck entirely. See the Massachusetts GLP-1 overview for statewide context.
Astra treats patients in Massachusetts through state-licensed physicians.
Local options
Renew Weight Loss & Med Spa (235 Chestnut St, Springfield, MA 01103) — The only Springfield clinic found that publishes real GLP-1 self-pay pricing, spread across several pages of its own site. Compounded semaglutide: $329/mo in-person or $299/mo on the "Express Lane" text-check-in tier; compounded tirzepatide: $429/mo in-person or $399/mo Express Lane. Brand-name tier (per the clinic's /medical-weight-loss page): semaglutide injection $424/mo ($75 clinic fee + $349 pharmacy), semaglutide pill $374/mo, tirzepatide $524/mo — the clinic's own page states "$75 to the clinic + $429 to the pharmacy = $524/mo," which doesn't actually add up (75+429=504); reported here as published, not corrected. All compounded tiers are flagged on-site as compounded-with-added-vitamins and not FDA-equivalent. Separately, the clinic advertises a "Medicare GLP-1 Bridge Program" (~$125/mo: $50 medication + $75 clinic fee) in effect since July 1, 2026 per its own blog post (published July 29, 2026) — no independent or CMS confirmation was found that this is an actual federal program, so treat it as an unverified vendor claim, not an established benefit. Against Astra's national $68/mo (sema) and $118/mo (tirz), most Renew tiers run roughly 3.4x-6.2x higher; the outlier is the unverified Medicare bridge tier, which lands close to Astra's own price. https://www.renewmedandspa.com/fullservice-glp1-weight-loss-care-in-springfield-ma(checked 2026-08-28)
Botastic Wellness Center (673 B White St, Springfield, MA 01108) — Advertises a medically supervised "Weight Loss Program" with personalized nutrition plans, but publishes no semaglutide/tirzepatide/GLP-1 dollar pricing anywhere on-site. Pricing is call-only: (413) 675-5333. Counted as evidence the local market is price-opaque outside of Renew. https://www.botasticwellness.com/(checked 2026-08-28)
New England Center for Functional Medicine (2 Medical Center Dr, Suite 202, Springfield, MA 01107) — Lists "Medical Weight Loss" among its services but discloses no GLP-1 drug pricing on-site. Requires a call (413-205-1200) or new-patient registration for a quote. Second confirmation that published local pricing is the exception, not the norm. https://necfunctionalmedicine.com/(checked 2026-08-28)
Frequently asked questions
How much does Ozempic, Wegovy, or Zepbound cost in Springfield, MA without insurance?
Locally, only one of the three Springfield weight-loss clinics checked publishes real GLP-1 pricing: Renew Weight Loss & Med Spa, at $299-$524/mo depending on formulation (compounded vs. brand-name) and tier (checked Aug 28, 2026). The other two clinics checked, Botastic Wellness Center and New England Center for Functional Medicine, require a phone call for a quote. Astra's national cash price is fixed at $68/mo for semaglutide and $118/mo for tirzepatide on a 12-month plan — the same in Springfield as everywhere else Astra operates.
Does MassHealth (Massachusetts Medicaid) cover semaglutide or tirzepatide for weight loss?
MassHealth's exact coverage rules for GLP-1 weight-loss prescriptions could not be independently confirmed as of this page's last review (Aug 28, 2026) — check directly with MassHealth or your plan for current coverage status. What doesn't change with your insurance status is Astra's price: $68/mo semaglutide and $118/mo tirzepatide, billed on a 12-month plan, nationwide.
Is Astra cheaper than local Springfield weight-loss clinics?
Based on the one Springfield clinic with published pricing (Renew Weight Loss & Med Spa), yes: Astra's $68/mo semaglutide and $118/mo tirzepatide run roughly 3.4x to 6.2x below most of Renew's compounded and brand-name tiers ($299-$524/mo). The one exception is Renew's own unverified "Medicare GLP-1 Bridge" tier (~$125/mo), which lands close to Astra's price rather than well above it.
What is Springfield's obesity rate compared to the rest of Massachusetts?
Springfield's adult obesity prevalence is 39.6% (CDC PLACES, BRFSS 2023 crude prevalence) — 4.7 points above Hampden County overall (34.9%) and 12.2 points above the Massachusetts state rate (27.4%). Massachusetts is a comparatively thin, high-income state; Springfield is a heavier, lower-income outlier within it.
Is Springfield, MA a designated health professional shortage area, and where can residents get specialist care?
Yes. HRSA lists an active Low-Income Population Primary Care HPSA covering Springfield/Chicopee/Holyoke, plus facility-level primary care, mental health, and dental HPSAs at Springfield's own federally qualified health centers (accessed Aug 28, 2026). Hospital-based specialist care is comparatively strong for a city this size — Baystate Medical Center runs an in-house Endocrinology & Diabetes department — but the primary-care front door that refers into that care is formally understaffed for Springfield's low-income population.
HRSA HPSA Data Downloads — Primary Care, Mental Health, Dental Health facility/geographic/population designations — https://data.hrsa.gov/data/download